Highly Active Antiretroviral Therapy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Condition: Acquired Immune Deficiency SyndromeInterventions: Drug: Lopinavir-ritonavir; Drug: EfavirenzSponsors: Rush University Medical Center; Rush University Medical Center; University of Chicago; University of Illinois; Ruth M. Rothstein CORE Center; Abbott; Gilead SciencesTerminated - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2008 Category: Research Source Type: clinical trials
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Condition: Acquired Immune Deficiency SyndromeInterventions: Drug: Lopinavir 400 mg/ritonavir 100 mg; Drug: EfavirenzSponsors: Rush University Medical Center; Rush University Medical Center; University of Chicago; University of Illinois; Ruth M. Rothstein CORE Center; Abbott; Gilead SciencesTerminated - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2008 Category: Research Source Type: clinical trials
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Condition: Acquired Immune Deficiency SyndromeInterventions: Drug: Lopinavir-ritonavir; Drug: EfavirenzSponsors: Rush University Medical Center; Rush University Medical Center; University of Chicago; University of Illinois; Ruth M. Rothstein CORE Center; Abbott; Gilead SciencesTerminated - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2008 Category: Research Source Type: clinical trials
